Greenwich LifeSciences, Inc.(GLSI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
GLSI Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Greenwich LifeSciences, Inc. (GLSI), a Healthcare sector company. GLSI is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of GLSI by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. GLSI trades on the Nasdaq exchange and files with the SEC under CIK 1799788. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GLSI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Greenwich LifeSciences, Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-3.9M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-11.2% YoYOperating Income
-10.3% YoYEPS (Diluted)
-6.7% YoYTotal Assets
+50.9% YoYOp. Cash Flow
-36.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-19.4M -11.2% | $-17.4M -95.8% | $-8.9M -13.6% | $-7.8M -71.2% | $-4.6M -145.3% | $-1.9M |
| Operating Income | $-19.4M -10.3% | $-17.6M -89.1% | $-9.3M -16.0% | $-8.0M -74.9% | $-4.6M -146.7% | $-1.9M |
| EPS (Diluted) | $-1.43 -6.7% | $-1.34 -94.2% | $-0.69 -13.1% | $-0.61 | — | — |
| Total Assets | $6.2M +50.9% | $4.1M -41.5% | $7.0M -48.1% | $13.5M -50.5% | $27.2M -5.1% | $28.7M |
| Operating Cash Flow | $-9.9M -36.4% | $-7.3M -12.2% | $-6.5M -4.5% | $-6.2M -44.5% | $-4.3M -272.2% | $-1.2M |
Get alerted when GLSI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Greenwich LifeSciences, Inc. including:
Top Institutional Holders of GLSI
BlackRock, Inc.
$11.4M485,854 shVANGUARD CAPITAL MANAGEMENT LLC
$6.5M278,190 shGEODE CAPITAL MANAGEMENT, LLC
$3.9M168,179 shSTATE STREET CORP
$3.4M143,086 shVANGUARD PORTFOLIO MANAGEMENT LLC
$1.9M80,861 shNORTHERN TRUST CORP
$1.9M80,228 shBank of New York Mellon Corp
$1.1M47,900 shVANGUARD FIDUCIARY TRUST CO
$1.1M45,965 shMORGAN STANLEY
$1.0M43,447 shGOLDMAN SACHS GROUP INC
$922.7K39,329 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $11.4M | 485,854 |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.5M | 278,190 |
| GEODE CAPITAL MANAGEMENT, LLC | $3.9M | 168,179 |
| STATE STREET CORP | $3.4M | 143,086 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.9M | 80,861 |
| NORTHERN TRUST CORP | $1.9M | 80,228 |
| Bank of New York Mellon Corp | $1.1M | 47,900 |
| VANGUARD FIDUCIARY TRUST CO | $1.1M | 45,965 |
| MORGAN STANLEY | $1.0M | 43,447 |
| GOLDMAN SACHS GROUP INC | $922.7K | 39,329 |
More Healthcare Companies
View all Healthcare →Put GLSI on your watchlist
Track score changes the day Greenwich LifeSciences, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GLSI a good stock to buy?
13F Pro's AI-powered analysis of Greenwich LifeSciences, Inc. (GLSI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GLSI are available on the GLSI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. GLSI is classified as a small company.
Which hedge funds own GLSI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GLSI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Greenwich LifeSciences, Inc.'s investment landscape.